Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

139.56 +1.44 (+1.05%)

Streaming Delayed Price Updated: 10:39 AM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

72 73 Next >

Upcoming Earnings Calls This Week: August 4th - August 10th, 2025

August 07, 2025

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...

Via MarketMinute

Topics Artificial Intelligence Economy

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Arcus (RCUS) Q2 Revenue Jumps 310% ↗

August 06, 2025

Via The Motley Fool

Gilead Sciences's Earnings Outlook ↗

August 06, 2025

Via Benzinga

Price Over Earnings Overview: Gilead Sciences ↗

July 25, 2025

Via Benzinga

Gilead Sciences Inc (NASDAQ:GILD) Meets Caviar Cruise Quality Investing Criteria ↗

August 06, 2025

The Caviar Cruise strategy identifies high-quality stocks like Gilead Sciences (GILD) for long-term investment, focusing on strong growth, ROIC, low debt, and solid cash flow. GILD excels in...

Via Chartmill

Topics Economy

Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 05, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

Tango (TNGX) Q2 Revenue Drops 52% ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

GILEAD SCIENCES INC (NASDAQ:GILD) Shows Strong Technical Breakout Potential with High Ratings ↗

August 04, 2025

Gilead Sciences (GILD) shows strong technical breakout potential with a high Technical Rating (10) and Setup Rating (8), indicating upward momentum and consolidation before a possible breakout.

Via Chartmill

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗

August 04, 2025

The upgraded score means Gilead is now outperforming 96% of all stocks in terms of the most important stock-picking criteria.

Via Investor's Business Daily

Pheton Holdings Dismisses Rumors Of Acquisition By Gilead, But Retail’s Extremely Optimistic ↗

August 01, 2025

pheton-holdings-dismisses-rumors-of-acquisition-by-gilead

Via Stocktwits

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Chinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers' ↗

July 30, 2025

Via Benzinga

Why Gilead Sciences Stock Slipped Today ↗

July 28, 2025

Changes in a federal healthcare authority could negatively impact one of the company's important businesses.

Via The Motley Fool

BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive ↗

July 28, 2025

The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting...

Via Stocktwits

Visa, Disney, Blackstone And A Health Care Stock On CNBC's 'Final Trades' ↗

July 28, 2025

Visa, which will report third quarter results on Tuesday, July 29, is analyst Stephanie Link's final trade.

Via Benzinga

Why Gilead Sciences (GILD) Stock Is Up Today

July 25, 2025

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 3% in the afternoon session after its long-acting HIV prevention injection, lenacapavir, received a recommendation for approval...

Via StockStory

Topics Stocks World Trade

Why Gilead Sciences Stock Just Popped ↗

July 25, 2025

Gilead stock is flashing "buy" in bright green letters.

Via The Motley Fool

Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales ↗

July 25, 2025

Gilead upgraded to Buy by Needham as Yeztugo gains physician favor, with sales forecast to reach $6.4 billion by 2035, exceeding prior estimates.

Via Benzinga

This Gilead Sciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗

July 25, 2025

Via Benzinga

Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet ↗

July 25, 2025

Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.

Via Stocktwits

Topics Workforce

Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention

July 25, 2025

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

July 24, 2025

From Gilead Sciences, Inc.

Via Business Wire

1 Value Stock Worth Your Attention and 2 Facing Headwinds

July 24, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Topics Supply Chain

Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year ↗

July 23, 2025

Via The Motley Fool

Topics Regulatory Compliance

Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know

July 23, 2025

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.

Via StockStory

Topics Stocks World Trade

NAFA Publishes New Fleet Safety Guidebook Aimed at Developing Safety-First Culture in all Organizations

July 23, 2025

Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content

Via News Direct

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

July 23, 2025

From Pomerantz LLP

Via GlobeNewswire

2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm

July 21, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Topics Supply Chain

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

July 18, 2025

From Pomerantz LLP

Via GlobeNewswire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.